Dengtang Liu

7PUBLICATIONS
19CO-AUTHORS
Personality and individual differencesPharmaceutical delivery technologiesCancer therapy (excl. chemotherapy and radiation therapy)Clinical psychologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 28, 2026
Predicting functional remission after antipsychotic discontinuation: a real-world study in schizophrenia.

|May 11, 2026
Efficacy and Safety of Risperidone Microspheres for Injection (II) in Patients With Schizophrenia Spectrum Disorders: A Prospective, Single-Arm, Multicenter Real-World Study.

|Mar 10, 2025
Optimal Treatment of Magnetic Seizure Therapy (MST) in Patients with Clozapine-Resistant Schizophrenia (CRS).

Qiong Xiang, Peiwei Xu, Zhaolin Zhai

|Dec 28, 2024
Prediction of functional remission in patients with schizophrenia after antipsychotic discontinuation (FURSAD): protocol for a real-world case-control study.

Chang Lu, Yuke Dong, Zhaolin Zhai

|Oct 16, 2024
Efficacy of Cortical-Hippocampal Target Intermittent Theta Burst Stimulation (iTBS) on Associative Memory of Schizophrenia: A Double-Blind, Randomized Sham-Controlled Trial.

Xuan Li, Qiong Xiang, Haixin Cen

|May 13, 2021
Dynamic functional connectivity and its anatomical substrate reveal treatment outcome in first-episode drug-naïve schizophrenia.

Zhe Zhang, Kaiming Zhuo, Qiang Xiang

Pageof 2

Frequent Collaborators

2 joint publications

Chang Lu

1 joint publications

Zhe Zhang

1 joint publications

John Suckling

1 joint publications

Yu Sun